Incorporating biological markers—such as inflammatory cytokines, cortisol rhythms, or measures of insulin sensitivity—into network models will provide an even more mechanistic understanding of the pathways that link depression and MetS. The gene discussed is INS; the disease is depressive symptom measurement.